June 20th 2025
The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.
China FDA Reforms Encourage Western Companies to Manufacture in China
December 10th 2015Changes in China’s Food and Drug Administration (cFDA) drug development and commercialization policies make it easier for multinationals and CMOs to manufacture in China for in-country use, reports CMO and consultant PaizaBio.